What's new

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised

Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised

Feb 11, 2025 - 16:26
 0
Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised
Human medicines European public assessment report (EPAR): Aprovel, irbesartan, Date of authorisation: 26/08/1997, Revision: 50, Status: Authorised
Read More

Tags:

Previous Article

Executive Steering Group on Shortages and Safety of Medicinal Products

Next Article

From new brands to innovation capabilities: Carlsberg’s expansion into soft drinks

Related Posts

Human medicines European public assessment report (EPAR): Cinqaero, reslizumab, Date of authorisation: 15/08/2016, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Apr 11, 2025  0

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0

Agenda of the CAT meeting 14-16 April 2025

Apr 14, 2025  0